Invention Grant
![Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity](/docs/US/2018-09-11/US10072010B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
-
Application No.: US15629481Application Date: 2017-06-21
-
Publication No.: US10072010B2Publication Date: 2018-09-11
- Inventor: Peng Li , Qiang Zhang , Robert Davis , Lawrence P. Wennogle
- Applicant: INTRA-CELLULAR THERAPIES, INC.
- Applicant Address: US NY New York
- Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee Address: US NY New York
- Agency: Hoxie & Associates LLC
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D487/22 ; C07D471/16 ; C07D471/14 ; A61K9/48 ; A61K9/50 ; A61K47/34 ; A61K47/38
![Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity](/abs-image/US/2018/09/11/US10072010B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]-quinoxaline compounds, represented by Formula 1, defined herein, free base or pharmaceutically acceptable salt forms of the compounds, pharmaceutical compositions thereof, and methods of treating conditions of the central nervous system therewith:
Public/Granted literature
- US20170283417A1 ORGANIC COMPOUNDS Public/Granted day:2017-10-05
Information query
IPC分类:
